Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Pfizer (NYSE: PFE) closedits acquisition of Wyeth earlier this month and the EU signed off on Merck 's (NYSE: MRK) acquisition of Schering-Plough (NYSE: SGP) last week. The monster acquisitions will give Pfizer and Merck some serious heft. Full Article at Town Hall
Related Articles
-
David Gardner called it. He’s up 1,334%! See what David’s recommending that you buy NEXT. Novartis (NYSE: NVS) has lots of moving parts, making it tricky to analyze, but it looks to me like the overall picture is pretty healthy. Full Article at Motley Fool
-
David Gardner called it. He’s up 1,334%! See what David’s recommending that you buy NEXT. This is starting to become a tradition or something. Full Article at Motley Fool
-
Merck & Co. (NYSE: MRK) on Thursday posted a bigger profit in the third quarter due to slightly higher sales and a huge gain from selling a business, according to Associated Press. Full Article at TransWorldNews
-
(NYSE: PFE) releases earnings on the other side of the sunrise, we'll get a last look at the company pre-Wyeth. Here's what you can expect from the pharmaceutical giant." Full Article at The Money Times
